The Patent Finder

NGM Biopharmaceuticals, Inc.

44 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

0
Ending by 2030
Jun 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 6 to 18, 2026 · next Dec 6
  • 1 fee due Jan 28, 2027
    The maintenance fee for Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject (US 9,089,525) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
  • 2 fees due Feb 6 to 22, 2027 · next Feb 6
  • 3 fees due Mar 17 to 26, 2027 · next Mar 17
  • 4 fees due Apr 8 to 30, 2027 · next Apr 8
  • 2 fees due Jun 19 to 30, 2027 · next Jun 19
  • 1 fee due Aug 18, 2027
    The maintenance fee for Compositions and Methods of Use for Treating Metabolic Disorders (US 10,562,965) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 1 fee due Sep 1, 2027
    The maintenance fee for Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases (US 9,273,107) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,951,966Compositions Comprising Variants and Fusions of FGF19 Polypeptides, and Uses and Methods Thereof for Treatment of Metabolic Disorders and Diseases
In force
 · High confidence
In forceHigh confidence
US 9,089,525Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject
In force
 · USPTO record
In forceUSPTO record
US 9,670,260Compositions comprising fusion variants of FGF19 polypeptides
In force
 · USPTO record
In forceUSPTO record
US 9,751,924Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject
In force
 · USPTO record
In forceUSPTO record
US 9,580,483Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetes
In force
 · USPTO record
In forceUSPTO record
US 11,065,302Compositions comprising fusion variants of FGF19 polypeptides
In force
 · USPTO record
In forceUSPTO record
US 10,413,590Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject
In force
 · USPTO record
In forceUSPTO record
US 10,195,250Compositions and Methods of Use for Treating Metabolic Disorders
In force
 · Low confidence
In forceLow confidence
US 9,273,107Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
In force
 · USPTO record
In forceUSPTO record
US 11,564,972Methods of Using Compositions Comprising Variants of FGF19 Polypeptides for Treating Primary Biliary Cirrhosis in a Subject
In force
 · Low confidence
In forceLow confidence
10 of 44 patents shown.
Pro members see all 44.
Pro members: see all 44 patents
Also on record, not counted in the 44: 29 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 5 abandoned · 37 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited